Skip to main content
. 2013 Jul 8;169(1):137–145. doi: 10.1111/bjd.12266

Fig 2.

Fig 2

Target Plaque Severity Score (TPSS) percentage change from baseline for (a) tofacitinib ointment 1 vs. vehicle 1 and (b) tofacitinib ointment 2 vs. vehicle 2 (full analysis set, no imputation). *Statistically significant (one-sided 90% upper confidence limit < 0); standard error bars may overlap at the prespecified statistical significance level. LSM, least squares mean.